Pure Global
PACTR201811835577312

Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1064/532nm), cryotherapy and chemical peels: A comparative study.

Sarah Ibrahim·Phase 4·Pan Africa Clinical Trials Registry·otherCompleted
Study focus
Disease/Condition
Skin and Connective Tissue Diseases
Intervention type
other
Sponsor & location
Primary sponsor
Sarah Ibrahim
Funder
Sarah Ibrahim Ismail
Location
Egypt
Timeline & enrollment
Phase
Phase 4
Start date
Jun 25, 2017
End date
Mar 25, 2018
Summary

The face and neck were chosen to verify the possibility of introducing TCA peels, 25 and 50%, as depigmenting agents and compare their efficacy with QS Nd:YAG laser (532 and 1064 nm) in depigmentation for vitiligo cases with undesired residual pigmented. The upper limb was chosen to evaluate and compare the effectiveness of phenol peel 88%, cryotherapy and QS Nd:YAG (532 and 1064 nm) laser in depigmentation of remaining normal-colored.

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201811835577312
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201811835577312 through Pure Global AI's free database. This Phase 4 trial is sponsored by Sarah Ibrahim and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.